Recombinant Bovine S100A7 Protein，GST

S100A7, also known as psoriasin, is a member of the S100 family of calcium-binding proteins, which are involved in various cellular processes, including cell proliferation, differentiation, and inflammation. Initially discovered in the context of psoriasis, S100A7 is highly expressed in the epidermis and has been implicated in the pathogenesis of several inflammatory skin disorders. Its overexpression is associated with abnormal keratinocyte function and contributes to the inflammatory response in these conditions. Beyond dermatological implications, recent studies have suggested that S100A7 may play a role in cancer progression and metastasis, particularly in breast cancer, where it is linked to poor prognosis. The production of recombinant S100A7 protein has been pursued to facilitate research into its biological functions, interactions with other proteins, and potential therapeutic applications. By using recombinant technology, researchers aim to elucidate the structure-function relationships of S100A7, explore its signaling pathways, and assess its role in modulating immune responses. Understanding the mechanistic role of S100A7 in both inflammation and cancer may provide valuable insights for the development of novel therapeutic strategies targeting its pathways, ultimately leading to improved treatment options for patients suffering from related diseases.